Last updated: October 23, 2026
Quick answer
In brief: a 54-year-old Indonesian patient traveled to Guangzhou for esophageal cancer treatment after his cancer spread to nearby lymph nodes. Doctors in several countries had called his case too uncertain to operate on. In China, he had three rounds of chemotherapy with immunotherapy, then minimally invasive surgery, and was discharged a week later.
A diagnosis with no clear next step
Umar, 54, was diagnosed with esophageal cancer in Indonesia. By the time doctors found it, the cancer had already spread to several lymph nodes in his chest. The local hospital could not operate. He consulted specialists at multiple hospitals abroad. Each one gave some version of the same answer. Surgery might be possible, but their experience with cases like his was limited, and the outcome was uncertain.
That uncertainty kept him from moving forward for weeks. Every option sounded the same: a cautious maybe, with little evidence behind it.
Looking at outcomes data instead of hospital reputations
A contact who was helping Umar with his case suggested a different way to compare his options. Instead of picking a hospital by name alone, look at how many similar cases a surgical team has treated, and what happened to those patients. Getting a second opinion from a doctor in China before committing to travel is one way patients make this kind of comparison from home. That search pointed Umar toward China.
He traveled to Guangzhou for an in-person visit with the hospital's chest surgery director. It was one of several Chinese hospitals that treat many complex chest cancer cases and track how patients do afterward.
Diagnosis and treatment in Guangzhou
In the consulting room, the chest surgery director walked Umar through his scans. He explained why each step of the plan mattered. In a comment translated from Chinese, the director told him that esophageal cancer is not necessarily untreatable. With the usual treatment, he said, more than 80% of patients caught at an early stage have a chance at a clinical cure, according to the original account of this visit.
Immunotherapy is a cancer drug that trains the body's own immune system to attack tumor cells. Doctors often give it alongside chemotherapy rather than on its own. Umar went through three rounds of chemotherapy combined with immunotherapy.
The treatment responded well. Umar went on to have minimally invasive surgery, an operation done through a few small cuts and a camera instead of one large incision. He was discharged a week later.
Recovery and going home
Umar stayed in Guangzhou for about a month while his recovery was monitored. At his last follow-up before flying home, the director told him, translated from Chinese, that he was recovering well. He could go home with peace of mind, the director said, and follow-up would continue from a distance until he had fully recovered.
| Step | What happened |
|---|---|
| Diagnosis, Indonesia | Esophageal cancer had spread to nearby lymph nodes; the local hospital could not operate |
| Consultation, Guangzhou | In-person visit with the hospital's chest surgery director |
| Chemotherapy and immunotherapy | Three rounds before surgery |
| Surgery | Minimally invasive esophagectomy |
| Discharge | About one week after surgery |
| Total stay in China | About one month before flying home |
How China treats esophageal cancer
A 2024 national survey of Chinese hospitals found that minimally invasive surgery plus chemotherapy or immunotherapy has become standard care for esophageal cancer in China. That is the same combination Umar had, rather than surgery alone. A separate 2024 study of nearly 3,500 newly diagnosed patients across 14 Chinese hospitals found that most patients with operable tumors had surgery as part of their first treatment.
Outcomes vary widely by how far the cancer has spread at diagnosis. A pooled analysis of hospital-based studies across China from 2000 to 2018 found roughly 74% of patients alive after one year and about 40% alive after five years (PMC6610307, 2019). Those figures cover every stage from early to advanced. They don't predict any one patient's outcome.
More foreign patients are coming to major Chinese hospitals each year. A 2025 government report said these hospitals treated about 1.28 million international patients in 2025, up 73.6% from three years earlier (Jiemian, 2025).
The cost of esophageal cancer treatment in China
Hospitals that treat international patients in China don't publish fixed prices for cancer care. Cost is usually quoted after a doctor has reviewed the case, and it depends on factors such as:
- the drugs used for chemotherapy or immunotherapy.
- the number of treatment cycles needed.
- the type of surgery performed.
Patients also need a China visa before they can travel for treatment. Ask for a written cost estimate before committing to the trip.
FAQ
Can foreigners get cancer treatment in China?
Yes. Major Chinese hospitals have international departments that register and treat non-Chinese patients. A 2025 government report said these hospitals treated about 1.28 million international patients that year, up 73.6% from three years earlier (National Health Commission, 2025). Each hospital sets its own intake process, so requirements vary by location and department.
Is esophageal cancer still treatable once it has spread to nearby lymph nodes?
It can be, depending on how far the cancer has spread and the patient's overall health. Treatment usually combines chemotherapy or immunotherapy with surgery, rather than surgery alone. The realistic outlook depends heavily on the stage at diagnosis, so ask a specialist to review the specific scans and pathology report.
Does China use minimally invasive surgery for esophageal cancer?
Yes. A 2024 national survey found that minimally invasive surgery paired with chemotherapy or immunotherapy, rather than open surgery alone, has become the standard approach at Chinese hospitals treating esophageal cancer.
How long does treatment and recovery typically take?
It varies by case. For the patient in this article, three rounds of chemotherapy combined with immunotherapy came before surgery. He was discharged about a week after the operation, then stayed in China for roughly a month before flying home.
What does esophageal cancer treatment in China cost?
Hospitals quote a cost range after reviewing a patient's records and proposed treatment plan, rather than publishing fixed prices. The total depends on the drug regimen, the number of treatment cycles, and the type of surgery needed, so get a written estimate first.
Sources
- 生命时报 (Life Times), "'快、省、好'！外籍患者眼中的中国医疗" ["Fast, affordable, good": what foreign patients see in Chinese healthcare], WeChat, April 14, 2026, https://mp.weixin.qq.com/s/v4ETBBDmiNddqxqn-FEFFA. This is the source of this patient's account. The treating doctor's name and the hospital's identity have been withheld in this adaptation beyond what the original report disclosed.
- Jiemian, report on the National Health Commission's 2025 report on international patient volumes at major Chinese hospitals, https://m.jiemian.com/article/14095369.html.
- Cancer Biology & Medicine, 2024 retrospective study on treatment patterns for newly diagnosed esophageal cancer across 14 Chinese hospitals, https://doaj.org/article/f40cdc8a63f440f9baeb6e5717099c8d.
- Thoracic Cancer, 2024 national survey on multimodality treatment standards for esophageal cancer in China, https://doaj.org/article/2137f4b5e76a4c839dbddd02d2cc6230.
- "Survival of Esophageal Cancer in China: A Pooled Analysis on Hospital-Based Studies From 2000 to 2018," PMC6610307, https://pmc.ncbi.nlm.nih.gov/articles/PMC6610307/.
Last verified: October 23, 2026
Editorial note: the statistics and treatment details in this article were checked against the sources listed above before publication.
How Goji Health can help
Goji Health is a US-China operated medical coordination company. We do not diagnose or treat. Our work is everything around the medical care, and for most international patients that starts with communication.
The patient in this article came to China through Goji Health. Before Umar traveled, our team reviewed his records with experienced Chinese general practitioners and replied within 24 to 48 hours. From there, he went through a trip-planning questionnaire covering flights, accommodation and what to expect at each step. Each patient has one English-speaking care manager, from the first message through the end of their stay. A medical escort met Umar in person at the hospital, made sure he and his doctors understood each other, and stayed reachable at any hour while he was in China.
Send your records for a case review
This article is for general information and is not medical advice. Individual results vary.